Various Intragastric Balloons Under Clinical Investigation
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Obesity is a chronic disease with an exponentially increasing incidence rate, and its negative effects are well documented in numerousstudies. As a result, the importance of bariatric therapy cannot be overemphasized, and many bariatric treatment methods with varyingmechanisms have been developed. Of the available treatment methods, intragastric balloons, introduced in the 1980s, have beenshown to be a safe and effective treatment modality; various intragastric balloon products have been developed and are currently beingwidely used in clinical settings. However, the disadvantages of intragastric balloons, such as unclear long-term weight loss benefitsand complications experienced during insertion and removal, preclude their wider use. In this review, we discuss different intragastricballoon products, focusing on those under clinical investigation, and suggest future research directions.
Abstract
Obesity is a chronic disease with an exponentially increasing incidence rate, and its negative effects are well documented in numerousstudies. As a result, the importance of bariatric therapy cannot be overemphasized, and many bariatric treatment methods with varyingmechanisms have been developed. Of the available treatment methods, intragastric balloons, introduced in the 1980s, have beenshown to be a safe and effective treatment modality; various intragastric balloon products have been developed and are currently beingwidely used in clinical settings. However, the disadvantages of intragastric balloons, such as unclear long-term weight loss benefitsand complications experienced during insertion and removal, preclude their wider use. In this review, we discuss different intragastricballoon products, focusing on those under clinical investigation, and suggest future research directions.
참고문헌 (45)
- Ng M, "Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the global burden of disease study 2013", Lancet, 384, pp.766~781 (2014)[DOI]
- Segula D, "Complications of obesity in adults: a short review of the literature", Malawi Med J, 26, pp.20~24 (2014)
- "Obesity treatment market size & forecast, by drugs (combination drugs, appetite suppressants, malabsorption & satiety drugs), by surgery & devices (adjustable gastric banding, Rouxen-Y gastric bypass, sleeve gastrectomy, biliopancreatic diversion with duodenal switch, endoscopic procedures) and trend analysis to 2024" (2016)[URL]
- Daniel S, "A complications-based clinical staging of obesity to guide treatment modality and intensity", Curr Opin Endocrinol Diabetes Obes, 20, pp.377~388 (2013)[DOI]
- Nguyen NT, "Trends in utilization of bariatric surgery, 2009-2012", Surg Endosc, 30, pp.2723~2727 (2016)[DOI]
- Vargas EJ, "Medical devices for obesity treatment: endoscopic bariatric therapies", Med Clin North Am, 102, pp.149~163 (2018)[DOI]
- Sullivan S, "Endoscopic bariatric and metabolic therapies: new and emerging technologies", Gastroenterology, 152, pp.1791~1801 (2017)[DOI]
- Kim SH, "Current status of intragastric balloon for obesity treatment", World J Gastroenterol, 22, pp.5495~5504 (2016)[DOI]
- Gleysteen JJ, "A history of intragastric balloons", Surg Obes Relat Dis, 12, pp.430~435 (2016)[DOI]
- Nieben OG, "Intragastric balloon as an artificial bezoar for treatment of obesity", Lancet, 1, pp.198~199 (1982)
- Gomez V, "Delayed gastric emptying as a proposed mechanism of action during intragastric balloon therapy: results of a prospective study", Obesity (Silver Spring), 24, pp.1849~1853 (2016)[DOI]
- Swidnicka-Siergiejko A, "Endoscopic treatment of obesity", Can J Gastroenterol, 25, pp.627~633 (2011)[DOI]
- Kentish SJ, "The role of gastrointestinal vagal afferent fibres in obesity", J Physiol, 593, pp.775~786 (2015)[DOI]
- Brooks J, "One-year adjustable intragastric balloons: results in 73 consecutive patients in the U.K", Obes Surg, 24, pp.813~819 (2014)[DOI]
- Machytka E, "Elipse, the first procedureless gastric balloon for weight loss: a prospective, observational, open-label, multicenter study", Endoscopy, 49, pp.154~160 (2017)
- Lecumberri E, "Effectiveness and safety of airfilled balloon Heliosphere <TEX>$BAG^{(R)}$<", TEX> in 82 consecutive obese patients, 2011, pp.21, 1508~1512
- Almeghaiseeb ES, "Efficacy of intragastric balloon on weight reduction: Saudi perspective", World J Clin Cases, 5, pp.140~147 (2017)[DOI]
- Zurawinski W, "Evaluation of the results of treatment of morbid obesity by the endoscopic intragastric balloon implantation method", Wideochir Inne Tech Maloinwazyjne, 12, pp.37~48 (2017)
- Keren D, "Intragastric balloons for overweight populations-1 year post removal", Obes Surg, 28, pp.2368~2373 (2018)[DOI]
- Gaggiotti G, "Adjustable totally implantable intragastric prosthesis (ATIIP)-Endogast for treatment of morbid obesity: one-year follow-up of a multicenter prospective clinical survey", Obes Surg, 17, pp.949~956 (2007)[DOI]
- Carvalho GL, "An improved intragastric balloon procedure using a new balloon: preliminary analysis of safety and efficiency", Obes Surg, 19, pp.237~242 (2009)[DOI]
- Lopasso FP, "A pilot study to evaluate the safety, tolerance, and efficacy of a novel stationary antral balloon (SAB) for obesity", J Clin Gastroenterol, 42, pp.48~53 (2008)[DOI]
- Martin CK, "Safety of the Ullorex oral intragastric balloon for the treatment of obesity", J Diabetes Sci Technol, 1, pp.574~581 (2007)[DOI]
- Ponce J, "The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity", Surg Obes Relat Dis, 11, pp.874~881 (2015)[DOI]
- "Summary of safety and effectiveness data (SSED): ORBERA™ intragastric balloon system" (2015)[URL]
- "Summary of safety and effectiveness data (SSED): Obalon balloon system" (2016)[URL]
- Borges AC, "Intragastric balloons in high-risk obese patients in a Brazilian center: initial experience", Rev Col Bras Cir, 45, pp.e1448~ (2018)
- Machytka E, "Adjustable intragastric balloons: a 12-month pilot trial in endoscopic weight loss management", Obes Surg, 21, pp.1499~1507 (2011)[DOI]
- Russo T, "BioEnterics intragastric balloon (BIB) versus spatz adjustable balloon system (ABS): our experience in the elderly", Int J Surg, 38, pp.138~140 (2017)[DOI]
- Daniel F, "Spatz 3 adjustable intragastric balloon: long-term safety concerns", Obes Surg, 26, pp.159~160 (2016)[DOI]
- Fateh Bazerbachi, "Recent Clinical Results of Endoscopic Bariatric Therapies as an Obesity Intervention", Clinical Endoscopy, 50(1), pp.42~50 (2017), 대한소화기내시경학회
- Alsabah S, "The safety and efficacy of the procedureless intragastric balloon", Surg Obes Relat Dis, 14, pp.311~317 (2018)[DOI]
- Angrisani L, "Elipse balloon: the pitfalls of excessive simplicity", Obes Surg, 28, pp.1419~1421 (2018)[DOI]
- Trande P, "Efficacy, tolerance and safety of new intragastric air-filled balloon (Heliosphere BAG) for obesity: the experience of 17 cases", Obes Surg, 20, pp.1227~1230 (2010)[DOI]
- Caglar E, "Gastric balloon to treat obesity: filled with air or fluid?", Dig Endosc, 25, pp.502~507 (2013)[DOI]
- De Castro ML, "Efficacy, safety, and tolerance of two types of intragastric balloons placed in obese subjects: a double-blind comparative study", Obes Surg, 20, pp.1642~1646 (2010)[DOI]
- Giardiello C, "Air-filled vs water-filled intragastric balloon: a prospective randomized study", Obes Surg, 22, pp.1916~1919 (2012)[DOI]
- Drozdowski R, "Small bowel necrosis as a consequence of spontaneous deflation and migration of an air-filled intragastric balloon - a potentially life-threatening complication", Wideochir Inne Tech Maloinwazyjne, 9, pp.292~296 (2014)
- Buzga M, "Effects of the intragastric balloon MedSil on weight loss, fat tissue, lipid metabolism, and hormones involved in energy balance", Obes Surg, 24, pp.909~915 (2014)[DOI]
- Buzga M, "Short-term outcomes of the new intragastric balloon End-<TEX>$Ball^{(R)}$<", TEX> for treatment of obesity, 2016, pp.11, 229~235
- Pezzo CT, "Efficacy and safety of intragastric balloon in the treatment of obesity in adolescent females", Nutrire, 42, pp.26~ (2017)[DOI]
- Neto MG, "Brazilian intragastric balloon consensus statement (BIBC): practical guidelines based on experience of over 40,000 cases", Surg Obes Relat Dis, 14, pp.151~159 (2018)[DOI]
- Do TN, "A magnetic soft endoscopic capsule-inflated intragastric balloon for weight management", Sci Rep, 6, pp.39486~ (2016)[DOI]
- Ghoz HM, "A pre-clinical animal study of combined intragastric balloon and duodenal-jejunal bypass sleeve for obesity and metabolic disease", Gastroenterology, 150(4 Suppl 1), pp.S231~S232 (2016)
- 최혁순, "Recent Trends in Endoscopic Bariatric Therapies", Clinical Endoscopy, 50(1), pp.11~16 (2017), 대한소화기내시경학회
